Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2003
05/28/2003EP1313719A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
05/28/2003EP1313718A2 Inhibitors of copper-containing amine oxidases
05/28/2003EP1313717A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313716A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313715A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
05/28/2003EP1313714A1 Valsartan salts
05/28/2003EP1313713A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313707A1 Quinoline derivatives as anti-inflammation agents
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313703A1 Prodrugs to nmda receptor ligands
05/28/2003EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
05/28/2003EP1313699A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
05/28/2003EP1313697A2 Immunoregulatory compounds, derivatives thereof and their use
05/28/2003EP1313509A2 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
05/28/2003EP1313507A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction
05/28/2003EP1313504A2 Methods and compositions for inhibiting angiogenesis
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1313497A1 Use of extracts of the cassia alata plant
05/28/2003EP1313484A2 Pharmaceutical formulation of salmeterol and fluticasone propionate
05/28/2003EP1313481A1 Pharmaceutical composition comprising condensed indole compound
05/28/2003EP1313480A2 Use of an arylaldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/28/2003EP1313479A1 Hair loss prevention
05/28/2003EP1313478A2 Method for treatment of migraine using pde5 inhibitors
05/28/2003EP1313470A1 Novel alicyclic imidazoles as h 3 agents
05/28/2003EP1313468A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
05/28/2003EP1313465A1 Composition and method for treatment of hypertriglyceridemia
05/28/2003EP1313463A1 Fatty acid analogues for the treatment of cancer
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1313448A1 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
05/28/2003EP1313426A4 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP1313426A2 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP1212313B1 7-carboxy-flavone derivatives, preparation method and therapeutic use
05/28/2003EP1206462B1 Heterocyclic compounds inhibiting angiogenesis
05/28/2003EP1161428B1 Pyrimidine compounds
05/28/2003EP1146885B1 Pre-conditioning against cell death
05/28/2003EP1143945B1 Carnitine supplemented diet to prevent sudden death syndrome in broiler breeder type poultry
05/28/2003EP1097145B1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them
05/28/2003EP1068198B1 5-heteroaryl substituted indoles
05/28/2003EP1056358B1 Use of d-tagatose as a prebiotic food component
05/28/2003EP1032415B1 Composition for the treatment of allergic conditions with cysteine and serine proteinase inhibitors
05/28/2003EP1014996B1 Saccharide-containing compositions for treating alzheimer's disease and other amyloidoses
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003EP0969833B1 Extension of the expression of transgenic proteins by immunomodulation with 15-deoxyspergualine with 15-deoxyspergualine
05/28/2003EP0966294B1 Bifurcated method to process aloe whole leaf
05/28/2003EP0941253B1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
05/28/2003EP0941100B1 Pharmaceutical compositions containing lamivudine and zidovudine
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003EP0871457B1 Isolated stromal cells and methods of using the same
05/28/2003EP0830604B1 Uses of apoptin
05/28/2003EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/28/2003EP0814789B1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003CN1420933A Method of inducing angiogenesis by micro-organs
05/28/2003CN1420926A Anti-angiogenic proteins and fragments and methods of use thereof
05/28/2003CN1420924A Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420885A Therapeutically useful new salts of CCK inhibitors, process for preparation thereof and pharmaceutical preparations contg. them
05/28/2003CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
05/28/2003CN1420883A N-aryl-(homopiperazinyl) cyclohexyl amines as 5-HT transporters
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420870A Modulators of dopamine neurotransmission
05/28/2003CN1420869A Modulators of dopamine neurotransmission
05/28/2003CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention
05/28/2003CN1420788A Improved treatment of neovascularization
05/28/2003CN1420787A Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents
05/28/2003CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
05/28/2003CN1420785A Method of treating cancer with anti-neurotrophin agents
05/28/2003CN1420783A Compositions and methods for tumor-targeted delivery of effector molecules
05/28/2003CN1420782A Immune enhancing compositions
05/28/2003CN1420776A Inhibition of cyclooxygenase-2 activity
05/28/2003CN1420775A Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
05/28/2003CN1420769A Method of treating osteoarthritis with inducible nitric oxide synthase inhibitors
05/28/2003CN1420768A Combination product comprising non-steroidal antiandrogen and EGFR tyrosine kinase inhibitor
05/28/2003CN1420766A Partial fatty acid oxidation inhibitors in treatment of congestive heart failure
05/28/2003CN1420765A Method for chemoprevention of prostate cancer
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420114A 2,3-disubstd. -4(3H)-quinazolones
05/28/2003CN1419936A Blood substitute of hemoglobin microcapsule and preparing method thereof
05/28/2003CN1419923A Refreshing liquid and preparing method thereof
05/28/2003CN1419912A Cyanidenon, apigenin -7-0-beta-D-glucoside use and related medicine
05/28/2003CN1109749C Pressure-mediated intracellular delivery of molecules or microparticles
05/28/2003CN1109689C 14 alpha, 17 alpha-C2-bridged 19-nor-progesterone derivatives
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109547C Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine deriv. and HMG-CoA reductase inhibitor
05/27/2003US6570020 Reacting 2-(3,3,3-trifluoropropyl),2-hydroxy,4a-benzyl-7-carboxy-1,2,3,4,4a,9,10,10a -octahydrophenanthrene with 2-methyl-3-(aminomethyl)pyridine to form the corresponding pyridyl-substituted amide at position 7
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6569997 Antibody specific for H4-1BB
05/27/2003US6569996 Antibody that specifically binds to the cadherin-5 cell adhesion recognition sequence
05/27/2003US6569995 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
05/27/2003US6569904 Via administration of toremifene for treatment or prevention of systemic/pulmonary hypertension, fibrosis, bronchial asthma, respiratory distress syndrome, myocardial infarction, thrombosis, congestive heart failure, and renal failure
05/27/2003US6569902 Inhibiting initiation or development of cancer by administering an effective dose of a nitrone free radical trapping agent to a subject
05/27/2003US6569899 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 1564